Valeant looks set to buy Bausch + Lomb

27 May 2013 - Deborah Wilkes

Archived

Valeant Pharmaceuticals International looks set to acquire the eye health specialist Bausch + Lomb from Warburg Pincus for US$8.7 billion in cash.

Click tags below for more information on topics:

Bausch Health

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: